文献速递免疫规划

表达含PEST序列的热休克蛋白70-主要膜蛋白II的重组尿酶缺陷型BCG增强抗结核保护效力

Enhanced protective efficacy against tuberculosis provided by a recombinant urease deficient BCG expressing heat shock protein 70-major membrane protein-II having PEST sequence.
PubMed 文献 · Vaccine · 2016-11-12

研究将PEST-HSP70-MMPII-PEST融合基因导入尿酶基因缺失的重组BCG(BCG-PEST),比较其与空载体BCG及BCG-DHTM的免疫效果。BCG-PEST更有效激活人单核细胞来源树突状细胞和自体初始CD8+、CD4+ T细胞,在小鼠中产生更持久的记忆型T细胞,单次皮下注射更有效减少后续气溶胶攻击的H37Rv和北京株在肺内的增殖,疫苗效果至少持续6个月。

要点

  • BCG-PEST分泌PEST-HSP70-MMPII-PEST融合蛋白,比空载体BCG或BCG-DHTM更有效激活人树突状细胞。
  • BCG-PEST通过树突状细胞有效激活自体初始CD8+和CD4+ T细胞,产生抗原特异性IFN-γ。
  • 单次皮下注射BCG-PEST在小鼠中更有效减少H37Rv和北京株在肺内的增殖,效果至少持续6个月。

核心结论

  • BCG-PEST可能能够有效控制结核在人群中的传播。

研究设计与样本

  • 研究将PEST-HSP70-MMPII-PEST融合基因导入尿酶基因缺失的重组BCG构建BCG-PEST,并与空载体BCG及表达HSP70-MMPII的尿酶基因缺失重组BCG(BCG-DHTM)比较免疫激活和保护效果。
  • 体外使用人单核细胞来源树突状细胞及自体初始CD8+和CD4+ T细胞评价免疫激活,体内使用C57BL/6小鼠评价记忆型T细胞产生及气溶胶攻击H37Rv和临床分离北京株后的肺内细菌增殖。

主要发现

  • BCG-PEST分泌PEST-HSP70-MMPII-PEST融合蛋白,在表型改变和细胞因子产生方面比空载体BCG或BCG-DHTM更有效激活人单核细胞来源树突状细胞。
  • BCG-PEST通过树突状细胞有效激活自体初始CD8+和CD4+ T细胞,使其以抗原特异性方式产生IFN-γ,这些T细胞激活与抗原呈递细胞中吞噬体成熟和蛋白酶体蛋白降解密切相关。
  • BCG-PEST在C57BL/6小鼠中比对照重组BCG更有效产生持久记忆型T细胞。
  • 单次皮下注射BCG-PEST比对照重组BCG更有效减少后续气溶胶攻击的H37Rv标准株和临床分离北京株在肺内的增殖。
  • BCG-PEST的疫苗接种效果至少持续6个月。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Enhancement of the T cell-stimulating ability of Mycobacterium bovis BCG (BCG) is necessary to develop an effective tuberculosis vaccine. For this purpose, we introduced the PEST-HSP70-major membrane protein-II (MMPII)-PEST fusion gene into ureC-gene depleted recombinant (r) BCG to produce BCG-PEST. The PEST sequence is involved in the proteasomal processing of antigens. BCG-PEST secreted the PEST-HSP70-MMPII-PEST fusion protein and more efficiently activated human monocyte-derived dendritic cells (DCs) in terms of phenotypic changes and cytokine productions than an empty-vector-introduced BCG or HSP70-MMPII gene-introduced ureC gene-depleted BCG (BCG-DHTM). Autologous human naïve CD8+ T cells and naïve CD4+ T cells were effectively activated by BCG-PEST and produced IFN-γ in an antigen-specific manner through DCs. These T cell activations were closely associated with phagosomal maturation and intraproteasomal protein degradation in antigen-presenting cells. Furthermore, BCG-PEST produced long-lasting memory-type T cells in C57BL/6 mice more efficiently than control rBCGs. Moreover, a single subcutaneous injection of BCG-PEST more effectively reduced the multiplication of subsequent aerosol-challenged Mycobacterium tuberculosis of the standard H37Rv strain and clinically isolated Beijing strain in the lungs than control rBCGs. The vaccination effect of BCG-PEST lasted for at least 6months. These results indicate that BCG-PEST may be able to efficiently control the spread of tuberculosis in human.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Tsukamoto Y, Maeda Y, Tamura T, et al. Enhanced protective efficacy against tuberculosis provided by a recombinant urease deficient BCG expressing heat shock protein 70-major membrane protein-II having PEST sequence. Vaccine. 2016. PMID: 27847173. doi:10.1016/j.vaccine.2016.10.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。